Enanta Pharmaceuticals
ENTA
#8126
Rank
$0.36 B
Marketcap
$12.50
Share price
3.31%
Change (1 day)
9.08%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of June 2026 : $0.10 Billion USD

According to Enanta Pharmaceuticals 's latest financial reports the company has $0.10 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-09-30$$64.71 M-49.76%
2024-09-30$$0.12 B-40.57%
2023-09-30$$0.21 B-32.55%
2022-09-30$$0.32 B-19.55%
2021-09-30$$0.39 B-12.33%
2020-09-30$$0.45 B-1.49%
2019-09-30$$0.46 B17.48%
2018-09-30$$0.39 B30.5%
2017-09-30$$0.30 B11.76%
2016-09-30$$0.26 B14.3%
2015-09-30$$0.23 B58.86%
2014-09-30$$0.14 B34.57%
2013-09-30$$0.11 B151.47%
2012-09-30$$43.92 M100.1%
2011-09-30$$21.95 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
$84.97 B 83,973.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$41.94 B 41,402.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-$5.89 Billion-5,925.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$20.24 B 19,933.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$41.98 B 41,440.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$22.31 B 21,983.15%๐Ÿ‡บ๐Ÿ‡ธ USA